Research and innovation in personalized medicine are surging. However, access ultimately hinges on managing information for clinical decision-making as well as converting it into evidence that can be used to help healthcare payers make coverage and reimbursement decisions.
In this session, Daryl Pritchard, senior vice president at the Personalized Medicine Coalition, discusses the value proposition for personalized medicine and gives an overview of the coverage, reimbursement and healthcare integration landscapes.
Building the value proposition for healthcare payers and providers.
Developing the necessary evidence to influence coverage and reimbursement decision-making.
Overcoming challenges to including precision medicine in clinical pathways and practice guidelines.